Engitix Therapeutics
Mike Platt is the co-founder and CEO of BlueCrest Capital Management, which he started in late 2000 after nearly a decade at JP Morgan.
Mike built BlueCrest into one of the world’s largest hedge fund firms; at its peak, it managed more than $35 billion in assets.
In 2015 he returned outside investors’ money, remaking BlueCrest into a family office. The firm has flourished since then, generating a 95% net return in 2020 after returns in the 50% range in 2016, 2017 and 2019.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Engitix Therapeutics
To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.